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Over the last several years, new evidence has kept pouring in about the remarkable effect
of caloric restriction (CR) on the conspicuous bedfellows- aging and cancer. Through
the use of various animal models, it is now well established that by reducing calorie
intake one can not only increase life span but, also, lower the risk of various age related
diseases such as cancer. Cancer cells are believed to be more dependent on glycolysis
for their energy requirements than normal cells and, therefore, can be easily targeted by
alteration in the energy-metabolic pathways, a hallmark of CR. Apart from inhibiting the
growth of transplantable tumors, CR has been also shown to inhibit the development
of spontaneous, radiation, and chemically induced tumors. The question regarding the
potentiality of the anti-tumor effect of CR in humans has been in part answered by
the resistance of a cohort of women, who had suffered from anorexia in their early
life, to breast cancer. However, human research on the beneficial effect of CR is still
at an early stage and needs further validation. Though the complete mechanism of the
anti-tumor effect of CR is far from clear, the plausible involvement of nutrient sensing
pathways or IGF-1 pathways proposed for its anti-aging action cannot be overruled. In
fact, cancer cell lines, mutant for proteins involved in IGF-1 pathways, failed to respond
to CR. In addition, CR decreases the levels of many growth factors, anabolic hormones,
inflammatory cytokines, and oxidative markers that are deregulated in several cancers. In
this review, we discuss the anti-tumor effect of CR, describing experiments done in vitro
in tumor models and in vivo in mouse models in which the tumor was induced by means
of radiation or chemical exposure, expressing oncogenes or deleting tumor suppression
genes. We also discuss the proposed mechanisms of CR anti-tumor action. Lastly,
we argue the necessity of gene expression studies in cancerous versus normal cells
upon CR.
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INTRODUCTION
Growing awareness that diet and environmental factors have a
profound effect in the initiation, promotion, and progression of
cancer argues that cancer is a preventable disease. In fact, alter-
ation in the eating habit from traditional to westernized diets
appears to correlate with the increased risk of many common can-
cers in both developed and developing countries (Baade et al.,
2009; Kolonel et al., 2004). For example, prostate cancer, which
was previously prevalent only in developed countries, showed an
increased incidence rate in less developed and developing coun-
tries, due to westernization of food habits (Baade et al., 2009).
Further, studies of ethnic and migrant groups in Hawaii showed
adaptation of Japanese immigrant cancer risk incidences to those
of native Hawaiian people (Kolonel et al., 2004). These obser-
vations reinforce the belief that environment and diet have an
impact on cancer development. The increased risk of breast can-
cer in Japanese women who migrated to US also supports the
influence of environment and diet on the pathogenesis of cancer
(Probst-Hensch et al., 2000). In addition, observational studies
showing a decreased risk of cancer in a population with a dietary
habit enriched for plant food, and limited consumption of ani-
mal fat and dairy products, also point toward the importance of
diet in cancer (Kushi et al., 2006). Obesity due to over eating has
been shown to be associated with increased risk of colon, breast
(in post-menopausal women), endometrium, kidney, esopha-
gus, pancreas, prostate, gallbladder, and liver cancer (Calle and
Kaaks, 2004). It is believed that increased food consumption
can influence the expression of genes involved in important
cellular functions, such as DNA repair, cell proliferation and dif-
ferentiation, and apoptosis, by altering the levels of metabolic
hormones and growth factors, and can lead to accumulation of
damage and mutations and ultimately malignant transforma-
tion (Hursting et al., 1999; Calle and Kaaks, 2004). Therefore, it
can be assumed that by controlling our diet we might also con-
trol cancer risk. Caloric restriction (CR), which can be defined
as “under nutrition without malnutrition,” has emerged as a
robust method to decrease cancer incidence, besides increasing
the life span of the individuals (Sell, 2003). CR has been shown to
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reduce the levels of many cancer-causing agents like anabolic
hormones, growth factors, and reactive oxygen species (ROS) in
animal models. Unfortunately, the exact metabolic adaptation
through which CR exhibits its anti-tumor effect is not completely
understood. However, at least in part, the mechanism responsi-
ble for the anti-tumor effect of CR involves a similar metabolic
adaptation as seen in the case of its anti-aging effect. The anti-
proliferative and pro-apoptotic properties of CR, in addition to its
ability to decrease oxidative stress andmaintain genomic stability,
could be responsible for its anti-tumor activity.
Here, we discuss the existing evidence regarding the anti-
tumor activity of dietary/energy restriction and factors and path-
ways crucial for its effect. We also discuss the putative parallel
mechanisms through which CR exerts both anti-aging and anti-
tumor activities. An insight into how anti-aging effects may also
lead to tumorigenesis is also provided. Finally, we discuss the
potential of CR interventions at clinical level.
CALORIC RESTRICTION AS A PROMISING NATURAL
APPROACH TO OVERCOME CANCER
Realization that both the environment and the diet of an indi-
vidual can influence the occurrence of cancer has heightened the
idea that cancer is a preventable disease. Epidemiological studies
have also shown a correlation between weight of an individ-
ual and development of tumors suggesting that controlling the
diet may contribute to cancer prevention (Tannenbaum, 1940,
1942; Collaborative Group on Epidemiological Studies of Ovarian
Cancer, 2012). In fact, beside the recognized effects that restric-
tion in calorie intake has on aging, increasing evidence also
supports a role of CR in inhibiting tumor. The first ever obser-
vation on the anti-tumor activity of CR was made in the early
1900’s. One of the very first experiments in mice and rats showed
that lowering the weight by CR can lower the frequency of var-
ious types of spontaneous tumors and other inducible tumors
(Mccay et al., 1939; Tannenbaum, 1940). More recently, exper-
iments carried out in tumor susceptible C3H/He female mice
showed that a change in diet to 70% of the ad-libitum diet could
single-handedly suppress the spontaneously occurring mammary
tumor, suggesting a newway of restricting tumor growth (Kharazi
et al., 1994). The fact that CR is linked to a reduction of the
levels of mouse mammary tumor virus (MMTV) RNA and inci-
dences of spontaneous mammary tumor further reinforces this
belief (Li et al., 1994). Furthermore, in an attempt to find out dif-
ferences in tumor biology with age, Pili et al. found that young
mice that were otherwise vulnerable to tumor growth and expan-
sion as compared to old mice, when fed on a caloric restricted
diet showed a decrease in the growth of transplantable tumors
and decreased angiogenesis (Pili et al., 1994). In addition, CR has
also been shown to be effective against chemically and radiation
induced leukemia, and mammary and liver tumors (Beth et al.,
1987; Ruggeri et al., 1989; Fu et al., 1994; Yoshida et al., 1997,
1999, 2006). The anti-tumor ability of CR was also observed in
animal models of pancreatic, colon, breast, prostate, and lung
tumor, proving it to be active against various kinds of cancer
(Figure 1A) (Bunk et al., 1992; Roebuck et al., 1993; Mukherjee
et al., 1999, 2002; Dirx et al., 2003a,b; Mai et al., 2003; Phoenix
et al., 2010; Lashinger et al., 2011). The inhibitory effect of CR
appears to depend on a caloric intake restriction ranging from
FIGURE 1 | Caloric Restriction (CR) and Cancer. (A) CR effectively inhibits
various kinds of cancer in animal models. (B) Correlation between decrease
in the incidence of tumor and severity of CR. (C) Demonstration of parallel
and opposing effects of CR on cancer and aging. The ability of CR to
decrease the levels of IGF-1 and ROS and inhibit the PI3K-AKT pathway can
simultaneously protect cells from aging and cancer. However, CR ability to
maintain telomere length and reduce the frequency of senescence can
promote cancer but may be also beneficial in delaying aging.
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25% up to 60% of ad-libitum levels, combined with adequate
intakes of essential nutrients. Interestingly, experiments in rats
showed that by increasing the degree of CR intervention, the
reduction in chemically-induced tumor incidence was intensi-
fied (Figure 1B) (Ruggeri et al., 1989; Kumar et al., 1990). Most
importantly, a very recent study, using a mouse model of post-
menopausal obesity, provided the evidence that CR can break the
obesity-cancer progression link offering a new hope to women
vulnerable to post-menopausal breast cancer (Nogueira et al.,
2012). Several studies usingmouse models of brain tumor showed
CR to be effective not only in non-invasive tumors but also in the
most aggressive and invasive forms of brain tumor, proving it to
have anti-proliferative, anti-angiogenic, and anti-invasive prop-
erties (Mukherjee et al., 2002, 2004; Zhou et al., 2007; Shelton
et al., 2010). Recently, CR has also been shown to be beneficial for
mice lacking the tumor suppressor p53. In fact, mice lacking p53
develop lymphoma by six months of age and die very early; how-
ever, when put on a calorie restriction diet, these mice live longer
due to decreased tumor incidence (Hursting et al., 1994, 1997).
This is very interesting as p53 is known to be non-functional
in almost all types of human cancer, either because of its own
mutation or mutation in its regulator/s. This last observation
again indicates that CR might constitute an effective interven-
tion for a prolonged healthier life. So far, the only tumor types
which failed to respond to calorie restricted diets are the tumors
carrying a mutation in either PI3K or PTEN genes, thus lead-
ing to the constitutive activation of the PI3K pathway (Kalaany
and Sabatini, 2009). Table 1 summarizes the amount of calorie
restriction in percentage or kcal/day or kcal/week in the above
mentioned studies.
PROPOSEDMECHANISMS FOR THE ANTI-TUMOR
ACTIVITY OF CALORIC RESTRICTION
The mechanisms responsible for the observed effect of CR in
aging, cancer and other chronic diseases are still under scrutiny.
The initial studies indicated the involvement of similar media-
tors and pathways for both the anti-aging and anti-tumor activity
of CR. Accumulation of cellular damage is assumed as one of
the initiating events in aging and cancer. ROS, which are natural
byproducts of cell normal metabolism and are capable of damag-
ing macromolecular components of the cells, including proteins,
lipids and DNA, are considered as the main culprit. In the cells,
ROS are neutralized by the action of anti-oxidant enzymes to
avoid oxidative damage. However, as the cells age, their capac-
ity to neutralize ROS diminishes, leading to accumulation of
macromolecular damage. Moreover, tumorigenesis is also fuelled
by accumulation of cellular damage, partly by increased intrin-
sic ROS stress due to oncogene stimulation, increased metabolic
activities, and mitochondrial malfunction (Pelicano et al., 2004).
Thus, regulation of oxidative stress could be the mechanism in
common between CR anti-tumor and anti-aging activities. In
fact, 25–40% CR was shown to maintain the otherwise dimin-
ishing levels of anti-oxidant defense systems in aging rodents
(Youngman et al., 1992). Further, 30% CR was shown to decrease
nitric oxide production in p53 deficient mice and delay tumorige-
nesis (Hursting et al., 1994, 2001; Mei et al., 1998). The ability of
CR to reduce oxidative stress was recently shown to be dependent
on SIRT3, a deacetylase (Qiu et al., 2010) and mice deficient in
SIRT3 were shown to be prone to both aging and cancer and failed
to respond to CR (Kim et al., 2010).
Another highly studied common mediator for the anti-tumor
and anti-aging activity of CR is IGF-1 (Insulin Growth Factor 1).
The involvement of IGF-1 in aging is supported by the availabil-
ity of nutrition studies in yeast, nematode, fruit fly and mouse
(Gems and Partridge, 2001). Mutants of Drosophila that exhib-
ited alteration of insulin/IGF-1 signaling pathways lived longer
(Clancy et al., 2001; Tatar et al., 2001). Life span extension in
C. elegans requires deregulation of Insulin/IGF-1 signaling (Lin
et al., 2001). The importance of IGF-1 in life span extension is
also observed in genetically modified mice defective for growth
hormone (GH) or IGF-1 production (Flurkey et al., 2001). These
mice live longer as compared to wild type mice. The produc-
tion of IGF-1 by the liver was shown to be stimulated by GH
(Isaksson et al., 1987). Many of the several biological roles of
GH seem to depend on its interaction with the growth hormone
receptor/binding protein (GHR/BP). Coschigano and colleagues
reported that mice with disruption in GHR/BP, although show-
ing high levels of circulating GH, had lower serum levels of IGF-1
in comparison to wild type, and lived longer (Coschigano et al.,
2000). All these studies show the importance of the IGF-1 path-
way in aging. CR was invariably shown to decrease the IGF-1
serum levels in animal studies (Weindruch and Walford, 1988;
Ruggeri et al., 1989; Hursting et al., 1993; Berrigan et al., 2002).
Interestingly, the injection of IGF-1 in the mice reversed the CR
effect. Furthermore, the ability of CR to regulate IGF-1 levels
and the Insulin/IGF-1 pathway could also be responsible for its
anti-tumor effect as an elevated IGF-1 serum level is associated
with an increased risk of breast, prostate, colon, and lung cancer
in humans (Chan et al., 1998; Hankinson et al., 1998; Schaefer
et al., 1998; Wolk et al., 1998; Ma et al., 1999; Yu et al., 1999).
Involvement of IGF-1 in cancer is further supported by its ability
to enhance the growth of a variety of cancer cell lines (Macaulay,
1992; LeRoith et al., 1995; Singh et al., 1996). The tumorigenic
property of IGF-1 is thought to be due to its ability to regulate
mitogenic and anti-apoptotic pathways (Resnicoff et al., 1995; Yu
and Rohan, 2000). In fact, in a transplantable and spontaneous
leukemia mouse model, CR has been shown to reduce serum
IGF-1 level and decrease leukemia cell proliferation (Hursting
et al., 1993). Interestingly, the anti-proliferative effect of CR on
leukemia cells was annulled by restoration of serum IGF-1 con-
centration (Hursting et al., 1993). Similarly, in p53 deficient mice,
restoration of IGF-1 levels reverses the beneficial effect of CR on
p-cresidine induced carcinogenesis (Dunn et al., 1997). Hence, it
can be assumed that, at least in part, CR modulation of IGF-1
mediates its anti-tumor and anti-aging effects.
Recently, the Forkhead box-O (FOXO) family of proteins has
been shown to be required for the anti-tumor and anti-aging
activity of CR (Greer et al., 2009; Yamaza et al., 2010). The
FOXO family of transcription factors is a direct target of the PI3K-
AKT pathway (Lin et al., 1997; Ogg et al., 1997). Activation of
the PI3K-AKT pathway leads to the phosphorylation and inacti-
vation of FOXO by AKT. However, its phosphorylation by AMPK
enhances its transcriptional activity (Greer et al., 2009). FOXO
transcription factors, by modulating specific targets genes (p21,
www.frontiersin.org August 2012 | Volume 3 | Article 318 | 3
Pallavi et al. CR: for a healthy prolonged life
Table 1 | Summary of the extent of caloric restriction and its effect on tumor growth.
Mice/Rat strain Control intake
(type or kcal/day)
Calorie restriction Outcome Reference
Amount in
kcal/day
% Restriction with
respect to
ad-libitum diet
Female sprague
dawley rats
50 kcal/day 35 kcal/day 30 Decreased MNU induced
carcinoma
Bunk et al., 1992
Sukling male
lewis rats
84 kcal/day ∼75.6 kcal/day,
∼71.5 kcal/day,
∼67.3 kcal/day,
∼58.9 kcal/day
10, 15, 20, 30 CR inhibited Azaserine-induced
preneoplastic lesion
The inhibition increased with more
severe restriction regimens
Roebuck et al., 1993
Balb/c Ad-libitum (standard
chow diet) or high
energy diet
- 30 CR reduced tumor growth and
metastasis in aggressive model of
hormone independent breast
cancer in syngeneic model using
triple negative 66cl4 tumor cells in
Balb/c mice
Phoenix et al., 2010
Apc (Min) mouse Ad-libitum AIN-76A
diet
- 40 Intestinal polyp was reduced by
57% by CR
Mai et al., 2003
Male FischerX
cophenhagen F1
rats
Ad-libitum AIN-76A
diet (61–69 kcal/day)
∼44.53 kcal/day (1) 30% total diet
restriction
(2) 30%
carbohydrate
restriction
(3) 30% lipid
restriction
Each of the 3 different restriction
diets inhibited R3327 tumor to the
same extent
Mukherjee et al.,
1999
Adult male SCID
mice
Ad-libitum AIN-76A
diet
(15.4 kcal/day)
11.1 kcal/day (1) 30% total diet
restriction
(2) 30% carbohydrate
restriction
(3) 30% lipid
restriction
Each of the 3 different restriction
diets inhibited LNGP human
carcinoma to the same extent
Mukherjee et al.,
1999
C57BL/6J and
BALBc/J-SCID
Ad-libitum PROLAB
Chow diet
(18 to up to
24 kcal/day)
13 kcal/day 30% CR reduced intra- cerebral CT-2A
tumor growth and angiogenesis in
syngeneic CT-2A experimental
mouse brain tumor
Mukherjee et al.,
2002
C57BL/6J and
BALBc/J-SCID
Ad-libitum PROLAB
Chow diet
(12–14 to up to
20–24kcal/day)
- 40% CR decreased vascularity (factor
VIII) and increased apoptosis in
three distinct models of brain tumor
(a) A malignant mouse astrocytoma
(CT-2A)
(b) A human glioma (U87-MG)
(c) Mouse ependymoblastoma
Mukherjee et al.,
2004
C57BL/6 Ad-libitum - 30% CR inhibited MMTV-Wnt1 tumor
growth in mouse model of
post-menopausal obesity
Nogueira et al., 2012
VM/DK (VM) Ad-libitum - 60% CR effectively reduce malignant
brain tumor growth in VM-M3 GBM
model
Shelton et al., 2010
p27, cyclin G2, BIM1, Bcl-6, FasL, GADD45, MnSOD, catalase),
promote a variety of cellular responses such as cell cycle arrest,
apoptosis, DNA repair and resistance to cellular stress (Greer and
Brunet, 2005), hence representing an attractive tumor suppressor
candidate. Interestingly, FOXO3 has been found to be deregu-
lated in breast cancer (Hu et al., 2004). Moreover, expression of
an active form of FOXO suppresses tumor in transplanted nude
mice (Hu et al., 2004; Yang et al., 2005). Further, expression of
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a constitutive active form of FOXO has been shown to inhibit
tumorigenesis in PTEN-null cells (Ramaswamy et al., 2002). An
indication of the involvement of FOXO in longevity comes from
a study in mutant worms where the increased longevity, due to
mutations in the insulin receptor and PI3K, was reversed by an
additional mutation in the FOXO ortholog Daf-16 (Lin et al.,
1997; Ogg et al., 1997; Kenyon, 2005). Studies in worm have
shown that CR ability to extend life span is dependent on AMPK,
which partly acts via FOXO (Greer et al., 2007). The inability of
CR to extend life span in the FOXO (daf-16)mutant strongly indi-
cates FOXO as a mediator of its anti-aging activity (Greer et al.,
2007). The requirement of FOXO in the antineoplastic effect of
CR has been shown using FOXO1 knockout heterozygous mice.
In comparison to wild type mice, these mice failed to recapitu-
late the beneficial effect of CR on tumor development. Wild type
mice on CR diet showed lower incidence of tumor and tumor
related deaths as compared to FOXO1 knockout heterozygous
mice (Yamaza et al., 2010), thus suggesting FOXO as a mediator
of CR anti-tumor effects as well.
THE DIVERGENT MECHANISM OF CALORIC
RESTRICTION IN AGING AND CANCER
The assumption that the anti-tumor ability of CR is a paral-
lel effect of its anti-aging activity and vice-versa is a debatable
issue. The regulation of GHs, oxidative stress, DNA damage,
and metabolic pathways by CR could simultaneously result in
its anti-tumor and anti-aging activities (Figure 1C). Recent stud-
ies have shown that CR reduces the frequency of senescent cells
in the liver and small intestine of mice (Wang et al., 2010). CR
effect on cellular senescence, a cause of aging, could be crucial
to its anti-aging activity (Goldstein, 1990; Wang et al., 2010).
However, this property of CR could also be beneficial to tumor
cells where induction of senescence is an effective tumor sup-
pressor mechanism (Lleonart et al., 2009). Further, CR has been
shown to maintain telomere length, another process important
for tumorigenesis (Feldser and Greider, 2007; Wang et al., 2010).
Experiment by Oliverras-Ferraros showed that cancer cell lines
can be maintained in culture for several months in the presence
of CR mimetics (CRM) (Oliveras-Ferraros et al., 2010). Gene
expression analysis suggests the retrogression from a more dif-
ferentiated state to a stem like primitive step in the presence of
CRM (Oliveras-Ferraros et al., 2010). While this finding promises
potential applications in the replacement of adult aging tissues, it
is, at the same time, a matter of concern as regards tumor biol-
ogy. Another interesting observation is the regulation of SIRT1
by p53 in response to CR. It seems that the induction of SIRT1
under the condition of nutrient deprivation requires occupancy
of its promoter by p53. Any mutation that affects the binding of
p53 to the SIRT1 promoter region affects SIRT1 up-regulation in
response to CR. Therefore, it appears that the SIRT1-mediated
beneficial effect of CR requires an active p53 and its binding on
SIRT1 (Naqvi et al., 2010). However, the ability of CR to exert its
ant-tumor effect in the absence of p53, further points towards the
singular regulation of aging and cancer by CR (Hursting et al.,
1997). In this context, it is essential to understand how CR car-
ries out both anti-tumor and anti-aging activities, and whether
its effects occurs through the same mechanism but with parallel
and opposing results on cancer and aging. Further investigations
are required (Figure 1C).
OTHER POSSIBLE MECHANISMS FOR THE
ANTI-TUMOR ACTIVITY OF CALORIC RESTRICTION
While one of the mechanisms responsible for CR-mediated ben-
eficial effects on cancer has been shown to involve the same
metabolic adaptation implicated in its anti-aging effects, the role
of other specific mediators and pathways cannot be ruled out.
One possibility could be the regulation of oncogenes and tumor
suppressor genes by CR. For example, gene expression analysis
of liver from mice fed on caloric restricted diet revealed signif-
icant changes in the genes involved in p53 dependent cell cycle
and apoptosis (Estep et al., 2009). One of the most highly up
regulated genes in the liver of CR fed mice was DNA-damage
inducible transcript 4 (Ddit4), a p53 controlled negative regula-
tor of the m-TOR pathway (Wei et al., 2006; Estep et al., 2009).
Ddit4 is a known tumor suppressor whose expression has shown
to be down regulated in a subset of human cancers (Deyoung
et al., 2008). CR mediated up-regulation of the Ddit4 transcript
could be one of many ways by which CR exerts its anti-tumor
effect. Analysis of pancreatic acinar cells from CR-fed Brown
Norway Rat revealed reduced expression of the c-Ha-Ras onco-
gene and reduced mutations in the p53 gene (Hass et al., 1993).
Further, study in mouse mammary tumor/v-Ha-ras transgenic
mice showed that a restricted diet decreases the tumor incidence
in these mice, may be through CRmediated increased levels of the
tumor suppressor p53 and scavenging enzymes and decreased lev-
els of c-erbB2 and v-Ha-ras RNA (Fernandes et al., 1995). p27/kip
is a cyclin dependent kinase inhibitor whose activity is deregu-
lated in various kinds of cancer (Slingerland and Pagano, 2000;
Bloom and Pagano, 2003). It has been proposed that CR inhibits
induced mammary carcinogenesis by arresting cell cycle progres-
sion via up-regulation of the expression of p27/kip (Zhu et al.,
1999). These observations further point towards the ability of CR
to modulate the expression of oncogenes and tumor suppressor
genes. Recently, epigenetic regulation by CR has been proposed
as one of many mechanisms through which CR controls aging
(Li et al., 2011). In fact, it has been shown that CR, by mod-
ulating epigenetic changes such as DNA methylation or histone
modification, controls the expression of oncogenes and tumor
suppressors (Hass et al., 1993; Li et al., 2010). The ability of CR
to hyper-methylate the promoter of proto-oncogenes such as Ras,
thus leading to their silencing, could contribute toward cancer
prevention (Hass et al., 1993).
A recent study using WI-38 (normal cells) and SV-antigen
transfected immortalizedWI-38 cells (precancerous cells) showed
that glucose restriction displayed an altered regulation of the
expression of both hTERT and the tumor suppressor p16 in nor-
mal and precancerous cells. In normal cells, glucose restriction
leads to increased expression of hTERT and decreased expression
of p16, leading to delayed aging. However, in precancerous cells,
glucose restriction leads to decreased expression of hTERT and
increased expression of p16 leading to apoptosis (Li et al., 2010),
suggesting that CR may mediate its anti-aging and anti-tumor
activities via differential regulation of oncogenes and tumor
suppressors by varied chromatin modifications. It can be also
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assumed that, through chromatin modulation, CR might bring
out differential gene expression in normal and cancerous cells.
Therefore, it would be interesting to examine the effect of CR on
the gene expression profile of normal and cancerous cells.
CLINICAL IMPLICATIONS OF CALORIC RESTRICTION
Although, reduction in calorie intake has emerged as a most
potent broadly acting intervention that prevents cancer in exper-
imental animals, its role at clinical level is yet to be defined.
There are limited numbers of designed and controlled studies
that are aimed to find out the efficacy of CR in humans. This is
mainly because of the unavailability of human volunteers will-
ing to follow a restricted diet regime despite CR claimed ability
to provide a healthy prolonged life. However, epidemiological
studies and observations from both natural and historical situ-
ations have indicated CR to be effective in humans too. Many
of these analyses were carried out from the answers to question-
naires filled by human volunteers regarding their history, such as
a study involving Spanish nursing residents indicating a benefi-
cial effect of CR (Roth et al., 1999). Interestingly, studies utilizing
data from cancer registries have shown a correlation between
weight loss during adulthood and occurrence of breast cancer.
Women’s cohorts who experienced a weight loss in adulthood
had reduced risk of developing breast cancer in comparison to
the ones who gained weight (Trentham-Dietz et al., 2000; Harvie
et al., 2005; Christou et al., 2008; Kawai et al., 2010). Likewise, a
retrospective study in Swedish women who suffered from severe
anorexia nervosa showed that they had a 53% lower incidence of
breast cancer than the Swedish general population (Michels and
Ekbom, 2004). Similarly, a decreased incidence of breast cancer
was observed in Danish women suffering from anorexia nervosa,
and in Norwegian pre-pubertal girls and Dutch women who had
been exposed to famine during World War II (van Noord and
Kaaks, 1991; Tretli and Gaard, 1996; Mellemkjær et al., 2001).
Further, the women of the Okinawa community, who follow a
traditional lower calorie diet, have lower incidence of breast can-
cer compared to other Japanese women (Willcox et al., 2007).
These observations indicated that starvation or CR during ado-
lescence and adulthood had clear impact on the development
of breast cancer, as observed in the rodents. Most interestingly,
the decreased prevalence of cancer and vascular diseases in the
Okinawa community, due to less calorie intake habit, is consid-
ered to be responsible for their lower mortality rate and for their
tumor free longer life (Kagawa, 1978). The questionnaire based
study of the Netherlands Cohort, who experienced severe CR as
adolescent during the Hunger Winter of World War II, has shown
that energy restriction during childhood and adolescence also
decreases the risk of colorectal and ovarian cancer (Dirx et al.,
2003a,b; Hughes et al., 2009; Schouten et al., 2011). All these stud-
ies point toward a role for CR in the modulation of human cancer
development.
Apart from these retrospective and historic observations, con-
trolled studies involving cancer patients also indicated a promis-
ing effect of CR on cancer. A study involving the enrollment of
obese persons in a weight loss program based on CR, showed a
reduction in their rectal cell proliferation, a biomarker for colon
carcinogenesis, suggesting that CR may prevent colon cancer
(Steinbach et al., 1994). Another case report using a ketogenic
diet that resulted in low blood glucose levels, as seen in caloric
restricted animals, showed a decrease in tumor metabolism
(Nebeling et al., 1995). These observations are encouraging and
suggestive of the clinical potential of CR and merit further
research.
FUTURE DIRECTIONS
Considering the robustness of the data regarding the beneficial
effect of CR on a diverse range of ailments, further scrutiny of CR
methods/application must be sought. As extensive CR is imprac-
tical to achieve in humans, studies directed at understanding the
mechanism of action of CR are essential. These kinds of studies
are required for the identification of effectors or pathways that
could possibly be targeted to achieve the beneficial effect of CR.
As discussed above, CR might exert its effect on various human
ailments through different mechanisms. However, no direct evi-
dence is available. Therefore, the mechanism of action of CR
should not be assumed universal and needs to be examined in
each disease condition.
The effect of CR on energy balance should not be ignored.
There is growing evidence to suggest the association of energy bal-
ance including diet, weight, adiposity, and physical activity with
tumorigenesis. It has been shown that increased energy expen-
diture due to increasing physical activities can reduce obesity
and might be beneficial in delaying tumorigenesis, at least in
some of the mouse models of mammary tumor (Cohen et al.,
1988; Thompson et al., 1995; Thompson, 1997; Jakicic and Otto,
2005). However, as results on the tumor inhibiting ability of
energy expenditure by exercise are controversial, a more exten-
sive examination is required (Cohen et al., 1992; Gillette et al.,
1997; Thompson et al., 1988). Additionally, a detailed and sys-
tematic quantitative analysis of the effect of energy intake, energy
expenditure and energy balance on tumorigenesis and aging is
warranted for the further scrutiny of this process.
One emerging alternative to CR is the use of CRMs. One of
the known CRMs, Rapamycin has been shown to be effective in
delaying aging as well as tumor growth, two main features of CR
benefit. However, this field is still very undeveloped and requires
FIGURE 2 | Schematic representation of CR known and potential
effects on cancer hallmarks.
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more attention. Of course, novel CRMs might be discovered in
the course of dissecting CR mechanisms.
Another unexplored area of research is the effect of CR on
tumor suppressor and tumor promoter genes. Does CR exert its
anti-tumorigenic effect through up-regulation of tumor suppres-
sor genes or down-regulation of oncogenes? Interestingly, the p53
family of tumor suppressors has been shown to negatively regu-
late the Insulin-like Growth Factor 1 (IGF-1) Receptor (IGFR-1),
an important player of the insulin receptor pathway, through
which CR has been proposed to exert its action (Bruchim et al.,
2009). Though, there is evidence that CR can increase apoptosis
in tumor cells and can inhibit angiogenesis and invasive proper-
ties of cancer cells, its effect on other hallmarks of cancer is not
explored (Mukherjee et al., 2002, 2004, 2008; Zhou et al., 2007;
Shelton et al., 2010). Therefore, it would be also interesting to
examine the ability of CR to target all the hallmarks of cancer
(Figure 2).
Another very exciting and unexplored area is that of stem cell
biology and CR. Although, a limited number of studies point
toward the inhibitory effect of CR on progenitor stem cell pro-
liferation, these need further validation (Yoshida et al., 1997).
Finally, studies using human subjects are foremost important for
the validation of CR efficacy. In all, we can say that CR is the
only natural approach emerging as a conqueror against aging and
cancer, and may pave our way toward a healthy prolonged life.
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